| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9484 | 
      | Human Intestinal Absorption | HIA+ | 0.9967 | 
      | Caco-2 Permeability | Caco2+ | 0.5948 | 
      | P-glycoprotein Substrate | Substrate | 0.6801 | 
      | P-glycoprotein Inhibitor | Inhibitor | 0.8656 | 
                                                     | Inhibitor | 0.8432 | 
      | Renal Organic Cation Transporter | Inhibitor | 0.6165 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.9031 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8634 | 
      | CYP450 2D6 Substrate | Substrate | 0.8919 | 
      | CYP450 3A4 Substrate | Substrate | 0.5304 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.6781 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 | 
        | CYP450 2D6 Inhibitor | Inhibitor | 0.8932 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 | 
      | CYP450 3A4 Inhibitor | Inhibitor | 0.6667 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8226 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6092 | 
                                                                    | Inhibitor | 0.7645 | 
      | AMES Toxicity | Non AMES toxic | 0.8925 | 
      | Carcinogens | Non-carcinogens | 0.8987 | 
      | Fish Toxicity | High FHMT | 0.7956 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9804 | 
      | Honey Bee Toxicity | Low HBT | 0.7564 | 
      | Biodegradation | Not ready biodegradable | 1.0000 | 
      | Acute Oral Toxicity | II | 0.7270 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5044 |